Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial (Q58003581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Luca Mastracci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

6

J Hatlebakk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

LOTUS trial collaborators

13 February 2020

11

object named as

LOTUS trial collaborators

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

S E Attwood

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C Ell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J-P Galmiche

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Bärthel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Långström

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

T Lind

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

L Lundell

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

23 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

959-971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

Long-term sequelae of Helicobacter pylori gastritis.

13 February 2020

cites work

1 reference

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

21 January 2018

1 reference

Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro

21 January 2018

1 reference

The achlorhydria-carcinoid sequence: role of gastrin

21 January 2018

1 reference

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole

21 January 2018

1 reference

Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas

21 January 2018

1 reference

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

21 January 2018

1 reference

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

21 January 2018

1 reference

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

Personal review: is profound acid inhibition safe?

21 January 2018

1 reference

Influence of gastric pH on gastric and jejunal flora

21 January 2018

1 reference

Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial

21 January 2018

1 reference

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial

21 January 2018

1 reference

Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience

21 January 2018

1 reference

The Sydney System: histological division

21 January 2018

1 reference

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.

21 January 2018

1 reference

Effects of acid suppression on microbial flora of upper gut.

21 January 2018

1 reference

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

21 January 2018

1 reference

Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors.

21 January 2018

1 reference

Modes of Helicobacter colonization and gastric epithelial damage

21 January 2018

1 reference

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

21 January 2018

1 reference

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

21 January 2018

1 reference

Safety of proton pump inhibitor exposure

21 January 2018

1 reference

Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial

21 January 2018

1 reference

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.

21 January 2018

1 reference

Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment.

21 January 2018

1 reference

Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps

21 January 2018

1 reference

Adverse effects of proton pump inhibitors

21 January 2018

1 reference

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

21 January 2018

1 reference

Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12052

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22998687%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference